Korro Bio (KRRO) EPS (Basic) (2018 - 2026)
Korro Bio's (KRRO) quarterly EPS (Basic) came in at -$1.07 in Q2 2026, up 60.88% on a YoY basis from -$0.67 in Q2 2025, and up 36.55% quarter-over-quarter from -$1.69 in Q1 2026.
Powered by 
Analysis
Korro Bio (KRRO) EPS (Basic) (2018 - 2026) Analysis & Trends
Korro Bio (KRRO) has reported EPS (Basic) for 9 consecutive years, with -$1.07 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 60.88% year-over-year to -$1.07; the trailing twelve-month figure through Jun 2026 stood at -$4.69 (up 40.23% YoY), and the FY2025 full-year result was -$9.93, down 34.3% from the prior year.
- EPS (Basic) rose to -$1.07 in Q2 2026 per KRRO's latest filing, from -$1.69 in the prior quarter.
- Across five years, EPS (Basic) topped out at $24.24 in Q4 2022 and bottomed at -$72.2 in Q1 2023.
- Historically, EPS (Basic) has averaged -$14.75 across 5 years, with a median of -$2.62 in 2025.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) jumped 177.47% in 2022, then slumped 589.53% in 2025.
- Over 5 years, EPS (Basic) stood at $24.24 in 2022, then plunged by 168.58% to -$16.63 in 2023, then jumped by 97.58% to -$0.4 in 2024, then plunged by 589.53% to -$2.78 in 2025, then soared by 61.36% to -$1.07 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$1.07, -$1.69, and -$2.78 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.46 Bn | 192.47 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.92 Bn | 176.75 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.37 Bn | 123.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.86 Bn | 73.87 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.29 Bn | 55.10 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 53.76 Bn | 48.62 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.16 Bn | 29.85 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.90 Bn | 30.62 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.13 Bn | 29.13 Bn | 1.16 Mn | -0.40 |
| 10 | Korro Bio | 225.43 Mn | 110.39 Mn | - | -1.07 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.07 |
| Mar 31, 2026 | -1.69 |
| Dec 31, 2025 | -2.78 |
| Sep 30, 2025 | -1.92 |
| Jun 30, 2025 | -2.74 |
| Mar 31, 2025 | -2.49 |
| Dec 31, 2024 | -0.40 |
| Sep 30, 2024 | -2.26 |
| Jun 30, 2024 | -2.43 |
| Mar 31, 2024 | -2.44 |
| Dec 31, 2023 | -16.63 |
| Sep 30, 2023 | -25.04 |
| Jun 30, 2023 | -63.83 |
| Mar 31, 2023 | -72.20 |
| Dec 31, 2022 | 24.24 |
| Sep 30, 2022 | -27.73 |
| Jun 30, 2022 | -30.43 |
| Mar 31, 2022 | -33.59 |
| Dec 31, 2021 | -31.29 |
| Sep 30, 2021 | -36.51 |